Global Blood Product Market Growth (Status and Outlook) 2023-2029

Global Blood Product Market Growth (Status and Outlook) 2023-2029

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
LPI (LP Information)' newest research report, the “Blood Product Industry Forecast” looks at past sales and reviews total world Blood Product sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Product sales for 2023 through 2029. With Blood Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Product industry.
This Insight Report provides a comprehensive analysis of the global Blood Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Product and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Product.
The global Blood Product market size is projected to grow from US$ 27700 million in 2022 to US$ 47120 million in 2029; it is expected to grow at a CAGR of 7.9% from 2023 to 2029.
The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Product market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Albumin
Immunoglobulin
Clotting Factor
Others
Segmentation by application
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd

Please note: The report will take approximately 2 business days to prepare and deliver.